Clinical Trials Logo
  1. Home
  2. Infantile Hemangioma
  3. NCT03842631

Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination

Infantile Hemangioma Clinical Trial

Official title:
Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination: a Single Center, Open Cohort Study.

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of Timolol Maleate treatment for different depth of infantile hemangioma based on B-ultrasonography. Based on the depth of hemangioma, patients will be proactively allocated to two groups. And then, all patients in both groups will receive topical timolol treatment in the same protocol and dosage.

Clinical Trial Description

Primary: Describe the efficacy of 0.5% topical timolol maleate drops in different depth of infantile hemangioma as assessed through IB-ultrasound. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03842631
Study type Observational
Source Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Contact XiaoXi Lin, PhD
Phone 021-23271699
Email linxiaoxi@126.com
Status Recruiting
Phase
Start date February 16, 2019
Completion date December 1, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT02505971 - Nadolol Versus Propranolol in Children With Infantile Hemangiomas Phase 3
Recruiting NCT04288700 - Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma Phase 4
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT01010308 - Nadolol for Proliferating Infantile Hemangiomas Phase 2
Completed NCT02913612 - Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) Phase 2
Completed NCT01673971 - Optical Tomographic Imaging of Infantile Hemangiomas
Recruiting NCT03237637 - Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas Phase 3
Recruiting NCT05479123 - Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas Phase 4
Terminated NCT01434849 - Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial) Phase 1
Completed NCT04105517 - Hemangiol, Post Marketing Surveillance Study
Completed NCT01512173 - Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo Phase 2
Completed NCT01056341 - Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy Phase 2/Phase 3
Not yet recruiting NCT04684667 - ''Efficacy of Propranolol in the Treatment of Infantile Hemangioma" Phase 2
Recruiting NCT03173352 - A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China N/A